Drug trial gets go-ahead after leaflet conflict

A DUBLIN hospital has reversed a controversial decision to postpone a cancer drug trial it deferred because patient information leaflets contained wording at odds with its Catholic ethos.

Last night the board of directors of the Mater Misericordiae University Hospital (MMUH) issued a statement saying the clinical trial of the lung cancer treatment Tarceva could now proceed.

In a significant climbdown, the board of directors decided it would “not be necessary to provide additional information to intending participants in the trial”, even though this was given as the reason for the trial’s deferral.